MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

ITD-1 10mM/1mL  | ≥98%

MedChem Express

ITD-1 is an inducer of TGFβ type II receptor degradation-1, is a potent and highly selective TGFβ pathway inhibitor (IC50 = 0.85 μM). IC50 value: 0.85 μM Target: TGFβ in vitro: ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is the first selective […]

More Information Supplier Page

ITD-1 5mg  | ≥98%

MedChem Express

ITD-1 is an inducer of TGFβ type II receptor degradation-1, is a potent and highly selective TGFβ pathway inhibitor (IC50 = 0.85 μM). IC50 value: 0.85 μM Target: TGFβ in vitro: ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is the first selective […]

More Information Supplier Page

ITD-1 10mg  | ≥98%

MedChem Express

ITD-1 is an inducer of TGFβ type II receptor degradation-1, is a potent and highly selective TGFβ pathway inhibitor (IC50 = 0.85 μM). IC50 value: 0.85 μM Target: TGFβ in vitro: ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is the first selective […]

More Information Supplier Page

ITD-1 50mg  | ≥98%

MedChem Express

ITD-1 is an inducer of TGFβ type II receptor degradation-1, is a potent and highly selective TGFβ pathway inhibitor (IC50 = 0.85 μM). IC50 value: 0.85 μM Target: TGFβ in vitro: ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is the first selective […]

More Information Supplier Page

ITD-1 100mg  | ≥98%

MedChem Express

ITD-1 is an inducer of TGFβ type II receptor degradation-1, is a potent and highly selective TGFβ pathway inhibitor (IC50 = 0.85 μM). IC50 value: 0.85 μM Target: TGFβ in vitro: ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is the first selective […]

More Information Supplier Page

ITE 10 mM * 1 mL  | 99.27%

MedChem Express

ITE is a potent endogenous agonist of aryl hydrocarbon receptor (AhR), binding directly to AHR, with a Ki of 3 nM. ITE also has immunosuppressive activity.

More Information Supplier Page

ITE 5 mg  | 99.27%

MedChem Express

ITE is a potent endogenous agonist of aryl hydrocarbon receptor (AhR), binding directly to AHR, with a Ki of 3 nM. ITE also has immunosuppressive activity.

More Information Supplier Page

ITE 10 mg  | 99.27%

MedChem Express

ITE is a potent endogenous agonist of aryl hydrocarbon receptor (AhR), binding directly to AHR, with a Ki of 3 nM. ITE also has immunosuppressive activity.

More Information Supplier Page

ITE 50 mg  | 99.27%

MedChem Express

ITE is a potent endogenous agonist of aryl hydrocarbon receptor (AhR), binding directly to AHR, with a Ki of 3 nM. ITE also has immunosuppressive activity.

More Information Supplier Page

ITE 100 mg  | 99.27%

MedChem Express

ITE is a potent endogenous agonist of aryl hydrocarbon receptor (AhR), binding directly to AHR, with a Ki of 3 nM. ITE also has immunosuppressive activity.

More Information Supplier Page

ITE 10mM/1mL  | ≥98%

MedChem Express

ITE is a aryl hydrocarbon receptor (AhR) agonist with Ki of 3 nM, and the estimated IC50 of ITE for OVCAR-3 cell proliferation was 0.2 nM. IC50 value: 0.2 nM (for OVCAR-3 cell), 3 nM (Ki) [1] Target: AhR in vitro: ITE is the endogenous high-affinity AhR agonist, possesses potent anticancer activity but the mechanism […]

More Information Supplier Page

ITE 50mg  | ≥98%

MedChem Express

ITE is a aryl hydrocarbon receptor (AhR) agonist with Ki of 3 nM, and the estimated IC50 of ITE for OVCAR-3 cell proliferation was 0.2 nM. IC50 value: 0.2 nM (for OVCAR-3 cell), 3 nM (Ki) [1] Target: AhR in vitro: ITE is the endogenous high-affinity AhR agonist, possesses potent anticancer activity but the mechanism […]

More Information Supplier Page

ITE 5mg  | ≥98%

MedChem Express

ITE is a aryl hydrocarbon receptor (AhR) agonist with Ki of 3 nM, and the estimated IC50 of ITE for OVCAR-3 cell proliferation was 0.2 nM. IC50 value: 0.2 nM (for OVCAR-3 cell), 3 nM (Ki) [1] Target: AhR in vitro: ITE is the endogenous high-affinity AhR agonist, possesses potent anticancer activity but the mechanism […]

More Information Supplier Page

ITE 10mg  | ≥98%

MedChem Express

ITE is a aryl hydrocarbon receptor (AhR) agonist with Ki of 3 nM, and the estimated IC50 of ITE for OVCAR-3 cell proliferation was 0.2 nM. IC50 value: 0.2 nM (for OVCAR-3 cell), 3 nM (Ki) [1] Target: AhR in vitro: ITE is the endogenous high-affinity AhR agonist, possesses potent anticancer activity but the mechanism […]

More Information Supplier Page

ITE 100mg  | ≥98%

MedChem Express

ITE is a aryl hydrocarbon receptor (AhR) agonist with Ki of 3 nM, and the estimated IC50 of ITE for OVCAR-3 cell proliferation was 0.2 nM. IC50 value: 0.2 nM (for OVCAR-3 cell), 3 nM (Ki) [1] Target: AhR in vitro: ITE is the endogenous high-affinity AhR agonist, possesses potent anticancer activity but the mechanism […]

More Information Supplier Page

ITI214 10 mM * 1 mL  | 99.58%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 5 mg  | 99.58%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 10 mg  | 99.58%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 50 mg  | 99.58%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 100 mg  | 99.58%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 10mM/1mL  | ≥98%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity against all […]

More Information Supplier Page

ITI214 5mg  | ≥98%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity against all […]

More Information Supplier Page

ITI214 10mg  | ≥98%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity against all […]

More Information Supplier Page

ITI214 50mg  | ≥98%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity against all […]

More Information Supplier Page

ITI214 100mg  | ≥98%

MedChem Express

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity against all […]

More Information Supplier Page

ITI214 (free base) 5mg  | ≥98%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity […]

More Information Supplier Page

ITI214 (free base) 10mg  | ≥98%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity […]

More Information Supplier Page

ITI214 (free base) 50mg  | ≥98%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity […]

More Information Supplier Page

ITI214 (free base) 100mg  | ≥98%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity […]

More Information Supplier Page

ITI214 (free base) 10mM/1mL  | ≥98%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). IC50 value: 58 pM (Ki) Target: PDE1 in vitro: ITI-214 exhibits picomolar inhibitory potency for PDE1, demonstrates excellent selectivity […]

More Information Supplier Page

ITI214 free base 5 mg  | >98.00%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 free base 10 mg  | >98.00%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 free base 50 mg  | >98.00%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITI214 free base 100 mg  | >98.00%

MedChem Express

ITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM).

More Information Supplier Page

ITIC  | Purity Not Available

MedChem Express

ITIC, non-fullerene acceptor, is an indacenodithienothiophene-based postfullerene electron acceptor, crystallizes in a profoundly different way as compared to fullerenes. ITIC has a superior thermal stability and undergoes a glass-crystal transition considerably below its high Tg of 180 °C.

More Information Supplier Page

ITIC-4F  | Purity Not Available

MedChem Express

ITIC-4F is an indacenodithienothiophene (IDTT)-based postfullerene electron acceptor. ITIC-4F has broad applicability in high-efficiency binary and ternary single-junction as well as tandem polymer solar cells (PSCs)[1].

More Information Supplier Page

ITK inhibitor 2 100 mg  | Purity Not Available

MedChem Express

ITK inhibitor 2 is a interleukin-2-inducible T-cell kinase (ITK) inhibitor extracted from patent WO2011065402A1, compound 4, with an IC50 of 2 nM.

More Information Supplier Page

ITK inhibitor 2 250 mg  | Purity Not Available

MedChem Express

ITK inhibitor 2 is a interleukin-2-inducible T-cell kinase (ITK) inhibitor extracted from patent WO2011065402A1, compound 4, with an IC50 of 2 nM.

More Information Supplier Page

ITK inhibitor 2 500 mg  | Purity Not Available

MedChem Express

ITK inhibitor 2 is a interleukin-2-inducible T-cell kinase (ITK) inhibitor extracted from patent WO2011065402A1, compound 4, with an IC50 of 2 nM.

More Information Supplier Page

Itopride (hydrochloride) 100mg  | ≥98%

MedChem Express

Itopride hydrochloride is an AChE inhibitor (acetylcholinesterase) and D2DR inhibitor. Target: AChE Itopride is a gastroprokinetic benzamide derivative. The IC50 of itopride with AChE (2.04 +/- 0.27 microM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3 +/- 3.4 nM), it was 10-fold less. The inhibitory effect […]

More Information Supplier Page

Itopride (hydrochloride) 500mg  | ≥98%

MedChem Express

Itopride hydrochloride is an AChE inhibitor (acetylcholinesterase) and D2DR inhibitor. Target: AChE Itopride is a gastroprokinetic benzamide derivative. The IC50 of itopride with AChE (2.04 +/- 0.27 microM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3 +/- 3.4 nM), it was 10-fold less. The inhibitory effect […]

More Information Supplier Page

Itopride (hydrochloride) 10mM/1mL  | ≥98%

MedChem Express

Itopride hydrochloride is an AChE inhibitor (acetylcholinesterase) and D2DR inhibitor. Target: AChE Itopride is a gastroprokinetic benzamide derivative. The IC50 of itopride with AChE (2.04 +/- 0.27 microM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3 +/- 3.4 nM), it was 10-fold less. The inhibitory effect […]

More Information Supplier Page

Itopride (hydrochloride) 1g  | ≥98%

MedChem Express

Itopride hydrochloride is an AChE inhibitor (acetylcholinesterase) and D2DR inhibitor. Target: AChE Itopride is a gastroprokinetic benzamide derivative. The IC50 of itopride with AChE (2.04 +/- 0.27 microM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3 +/- 3.4 nM), it was 10-fold less. The inhibitory effect […]

More Information Supplier Page